Egypt chosen as headquarters of the Arab Medicines Agency (WAAD) after approval by the Council of Arab Health Ministers and the Economic and Social Council of the League of Arab States
Deputy Prime Minister and Minister of Health announces that Egypt has been chosen as the headquarters of the Arab Medicines Agency (WAAD) after approval by the Council of Arab Health Ministers and the Economic and Social Council of the League of Arab States
Deputy Prime Minister and Minister of Health extends his sincere thanks and appreciation to President Abdel Fattah El-Sisi for his continuous support for the file of establishing the Arab Medicines Agency (WAAD)
Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, announced the culmination of Egyptian efforts to establish the Arab Medicines Agency (WAAD) and the selection of the Arab Republic of Egypt as its headquarters, following the approval of the Council of Arab Health Ministers and the Economic and Social Council of the League of Arab States, extending his thanks to President Abdel Fattah El-Sisi for his constant and unlimited support for all the steps of establishing the Agency, which extended over more than 30 months.
Dr. Hossam Abdel Ghaffar, the official spokesperson of the Ministry of Health and Population, stressed that the selection of Egypt as headquarters of the Arab Medicines Agency (WAAD) stems from Egypt's standing and leadership in the pharmaceutical market in the Arab region. The Agency represents a great opportunity to support Arab leadership in pharmaceutical innovation and improve public health, in addition to its positive economic return in the region by attracting investment and facilitating pharmaceutical trade.
«Abdel Ghaffar» added that the Agency aims to establish a unified regulatory framework for drug approval procedures and standards in Arab countries, deepen regional and international cooperation to promote pharmaceutical research, development and innovation, and build the regulatory capacity of Member States through training, knowledge exchange and technical support for the bodies concerned with the pharmaceutical industries, in addition to improving access to safe medicines and encouraging research and development of new treatments.
«Abdel Ghaffar» pointed out that the founding rules of the Agency stress that Arab countries are not obliged to purchase medicines jointly, to register medicines jointly or to accredit pharmaceutical factories jointly, and in a manner that does not contravene the regulations in force in Arab countries, unless the Arab countries agree otherwise.
«Abdel Ghaffar» explained that the idea of establishing the Arab Medicines Agency began with an Egyptian proposal, placed on the agenda of the 56th session of the Council of Arab Health Ministers, held in March 2022 at the headquarters of the League of Arab States in Cairo. The Egyptian side then drew up the technical concept for the Arab Medicines Agency during 2022 through several technical coordination meetings, in which representatives of the Ministry of Health and Population, headed by the Assistant Minister of Health for Public Health Initiatives, and representatives of the Drug Authority took part.
«Abdel Ghaffar» pointed out that the past months witnessed many meetings and joint working sessions between the Egyptian side, the Council of Arab Health Ministers and the Economic and Social Council of the League of Arab States, until the convening of the 114th session of the Economic and Social Council from 1 to 5 September 2024 at the headquarters of the League of Arab States. Several lengthy discussions took place on the decision to establish the Agency, until the final decision on establishing the Arab Medicines Agency was issued, including welcoming Egypt's hosting of the headquarters of the Arab Medicines Agency and thanking it for the steps it has taken to bring about its establishment.